| Issue Date | Title | Author(s) |
| 2009 | Identification of major factors influencing ELISpot-based monitoring of cellular responses to antigens from mycobacterium tuberculosis | Smith, SG; Joosten, SA; Verscheure, V; Pathan, AA; McShane, H; Ottenhoff, THM; Dockrell, HM; Mascart, F |
| 2017 | What have we learnt about BCG vaccination in the last 20 years? | Dockrell, HM; Smith, SG |
| 27-Sep-2018 | Immunological correlates of mycobacterial growth inhibition describe a spectrum of tuberculosis infection | O’Shea, MK; Tanner, R; Müller, J; Harris, SA; Wright, D; Stockdale, L; Stylianou, E; Satti, I; Smith, SG; Dunbar, J; Fletcher, TE; Dedicoat, M; Cunningham, AF; McShane, H |
| 30-Apr-2019 | RUTI vaccination enhances inhibition of mycobacterial growth ex vivo and induces a shift of monocyte phenotype in mice | Prabowo, SA; Painter, H; Zelmer, A; Smith, SG; Seifert, K; Amat, M; Cardona, PJ; Fletcher, HA |
| 2017 | Whole Blood Profiling of Bacillus Calmette–Guérin-Induced Trained Innate Immunity in Infants Identifies Epidermal Growth Factor, IL-6, Platelet-Derived Growth Factor-AB/BB, and Natural Killer Cell Activation | Smith, SG; Kleinnijenhuis, J; Netea, MG; Dockrell, HM |
| 4-Sep-2018 | Cross-laboratory evaluation of multiplex bead assays including independent common reference standards for immunological monitoring of observational and interventional human studies | Van Meijgaarden, KE; Khatri, B; Smith, SG; Drittij, AMFH; De Paus, RA; Goeman, JJ; Ho, MM; Dockrell, HM; McShane, H; Joosten, SA; Ottenhoff, THM |
| 2017 | Assay optimisation and technology transfer for multi-site immuno-monitoring in vaccine trials | Smith, SG; Harris, SA; Satti, I; Bryan, D; Walker, KB; Dockrell, HM; McShane, H; Ho, MM |
| 19-Mar-2019 | Historical BCG vaccination combined with drug treatment enhances inhibition of mycobacterial growth ex vivo in human peripheral blood cells | Prabowo, SA; Zelmer, A; Stockdale, L; Ojha, U; Smith, SG; Seifert, K; Fletcher, HA |
| 14-Dec-2018 | Human Hookworm Infection Enhances Mycobacterial Growth Inhibition and Associates With Reduced Risk of Tuberculosis Infection | O'Shea, MK; Fletcher, TE; Muller, J; Tanner, R; Matsumiya, M; Bailey, JW; Jones, J; Smith, SG; Koh, G; Horsnell, WG; Beeching, NJ; Dunbar, J; Wilson, D; Cunningham, AF; McShane, H |
| 31-Jan-2019 | Optimisation, harmonisation and standardisation of the direct mycobacterial growth inhibition assay using cryopreserved human peripheral blood mononuclear cells | Tanner, R; Smith, SG; van Meijgaarden, KE; Giannoni, F; Wilkie, M; Gabriele, L; Palma, C; Dockrell, HM; Ottenhoff, THM; McShane, H |
